Literature DB >> 31535735

Nonalcoholic Fatty Pancreas Disease.

Nihar Shah1, Jason P Rocha2, Neal Bhutiani3, Omer Endashaw1.   

Abstract

Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.
© 2019 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  fatty liver; fatty pancreas; metabolic syndrome; obesity; pancreas; pancreatic disease

Mesh:

Year:  2019        PMID: 31535735     DOI: 10.1002/ncp.10397

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  9 in total

1.  The relation of CT quantified pancreatic fat index with visceral adiposity and hepatic steatosis.

Authors:  Aysegul Gursoy Coruh; Caglar Uzun; Zehra Akkaya; Atilla Halil Elhan
Journal:  Turk J Surg       Date:  2020-09-28

Review 2.  Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Authors:  T D Filippatos; K Alexakis; V Mavrikaki; D P Mikhailidis
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

Review 3.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

Review 4.  Circadian Genes as Therapeutic Targets in Pancreatic Cancer.

Authors:  María García-Costela; Julia Escudero-Feliú; Jose D Puentes-Pardo; Sara Moreno San Juán; Sonia Morales-Santana; Sandra Ríos-Arrabal; Ángel Carazo; Josefa León
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-11       Impact factor: 5.555

5.  The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates.

Authors:  Bedriye Koyuncu Sokmen; Tolga Sahin; Alihan Oral; Erdem Kocak; Nagihan Inan
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

6.  Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid.

Authors:  Chuntian Hong; Yonghao Yan; Liyang Su; Debo Chen; Changqing Zhang
Journal:  Open Med (Wars)       Date:  2022-03-31

Review 7.  Fatty Pancreas: Disease or Finding?

Authors:  Lucas de Lucena Simões E Silva; Matheus Santos de Sousa Fernandes; Eline Autran de Lima; José Tadeu Stefano; Claudia P Oliveira; José Jukemura
Journal:  Clinics (Sao Paulo)       Date:  2021-02-22       Impact factor: 2.365

Review 8.  Microbiota in Pancreatic Diseases: A Review of the Literature.

Authors:  Tommaso Schepis; Sara S De Lucia; Enrico C Nista; Vittoria Manilla; Giulia Pignataro; Veronica Ojetti; Andrea Piccioni; Antonio Gasbarrini; Francesco Franceschi; Marcello Candelli
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

Review 9.  Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.

Authors:  Ming-Ling Chang
Journal:  Biomedicines       Date:  2022-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.